No ADRs either at T1 or T2 (n = 978) | Reported developing ADRs between T1 and T2 (n = 217) | Χ2 | df | P values | |||
n | % | n | % | ||||
Sociodemographic variables (T1) | |||||||
Gender | 24.37 | 1 | <0.000 | ||||
Females | 538 | 55.0 | 159 | 73.3 | |||
Males | 440 | 45.0 | 58 | 26.7 | |||
Education | 8.53 | 3 | 0.036 | ||||
Basic | 121 | 12.4 | 19 | 8.8 | |||
Secondary | 227 | 23.2 | 59 | 27.2 | |||
Secondary vocational | 326 | 33.3 | 87 | 40.1 | |||
Higher | 304 | 31.1 | 52 | 24.0 |
Number of EHIF diagnoses is the number of diagnoses recorded in the Estonian Health Insurance Fund for the year of data collection.
Number of medicines taken is the number of medicines taken during the previous 2 months, either regularly or for treating specific diseases.
ADR, adverse drug reaction; BMI, body mass index; BP, blood pressure; EHIF, Estonian Health Insurance Fund; FFM, Five-Factor Model; NEO PI-3, NEO Personality Inventory-3; T1, first measurement; T2, second measurement (on average 5.3 years after T1).